Key Insights

Highlights

Success Rate

65% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

16.7%

7 terminated out of 42 trials

Success Rate

65.0%

-21.5% vs benchmark

Late-Stage Pipeline

10%

4 trials in Phase 3/4

Results Transparency

0%

0 of 13 completed with results

Key Signals

65% success

Data Visualizations

Phase Distribution

28Total
Not Applicable (12)
Early P 1 (2)
P 1 (7)
P 2 (3)
P 4 (4)

Trial Status

Completed13
Unknown12
Terminated7
Recruiting5
Not Yet Recruiting5

Trial Success Rate

65.0%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (42)

Showing 20 of 20 trials
NCT04844827CompletedPrimary

Pleural Carcinomatosis Tissue Banking

NCT05461430CompletedPrimary

Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

NCT06436807Completed

PMCF Study of the CE-marked Drainova® ArgentiC Catheter

NCT07443020Phase 1Not Yet Recruiting

Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors

NCT07192900Phase 1Recruiting

Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease

NCT07167992Not ApplicableNot Yet Recruiting

Comparison of Talc Slurry Versus Talc Insufflation: A Study on Effectiveness, Safety, and Hospital Outcomes in Pleurodesis

NCT07208409Not ApplicableNot Yet RecruitingPrimary

Pleurodesis in Small-bore Chest Tube

NCT06946498Not ApplicableRecruiting

First Local Anaesthesia Thoracoscopy for Pleural Effusion Diagnosis.

NCT04669223Not ApplicableTerminatedPrimary

Comparing Different Sizes of Small-bore Chest Drains in Malignant Pleural Effusion

NCT04684459Early Phase 1Recruiting

Dual-targeting HER2 and PD-L1 CAR-T for Solid Tumors

NCT06512896Not ApplicableRecruiting

Clinical Study on Intraluminal Injection of FOLactis

NCT05268172Phase 1RecruitingPrimary

IFN-γ Combined With T Cells in the Treatment of Refractory Malignant Pleural Effusion and Ascites

NCT06275178Not Yet Recruiting

Medical Thoracoscopy for Diagnosing Unexplained Pleural Effusion: a National Multicenter Retrospective Study

NCT05278975Phase 1Unknown

Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma

NCT02517749Not ApplicableCompletedPrimary

Out Patient Talc Slurry Via Indwelling Pleural Catheter for Malignant Pleural Effusion Vs Usual Inpatient Management

NCT05910112Unknown

Prospective Data Collection on Clinical, Radiological and Patient Reported Outcomes After Pleural Intervention

NCT04749602Phase 2Completed

Intrapleural Instillation of the Nivolumab in Cancer Patients With Pleural Effusion.

NCT05693727Not Yet RecruitingPrimary

Cancer Ratio,Pleural Fluid Adenosine Deaminase,Lactate Dehydrogenase, interferonY, Tumor Necrosis Factor,and Interleukins{2,12,18}for Differentiation Between Malignant and Non Malignant Pleural Effusion

NCT04670562UnknownPrimary

Longitudinal Follow up of Patients With Pleural Effusion

NCT05077111Phase 4UnknownPrimary

A Comparative Study Between Regional Anesthesia in Thoracoscopes and the Conventional General Anesthesia

Scroll to load more

Research Network

Activity Timeline